Lundbeck's antipsychotic Serdolect safe for some patients, US panel says
This article was originally published in Scrip
Executive Summary
Lundbeck's atypical antipsychotic Serdolect (sertindole) could be safely used by some schizophrenia patients but is not safe for broad treatment owing to cardiac risks, a US FDA advisory panel has said.